AMA counts to 10 before voting drug shortages position

Unlike the many individual patients who report feeling powerless when they are unable to get drugs they need, doctors are plying their strength in numbers under the banner of the American Medical Association to catalyze a solution. They've voted their support for FDA and Congress to require contingency production plans of the makers of medically necessary drugs to ensure continuous supply. And members agreed to support financial incentives for drugmakers to continue production of scarce medicines, but only after ruling out the idea of financial penalties for those that don't promptly attempt to rectify shortages. Story

Suggested Articles

While no shortages of drug supplies have been reported, governments are trying to get a handle on what they can do if they materialize.

Branded drug sales in China could suffer in the short term as marketing activities for new meds are limited to reduce the risk of contagion.

Korean CDMO Samsung Biologics is expanding and China API maker WuXi STA opened a 30,000-square-foot oligonucleotide manufacturing facility.